Alcidion Announces Board Change with Director Departure

An announcement from Alcidion Group Limited ( (AU:ALC) ) is now available.

Alcidion Group Limited has announced a change in its board of directors, with Victoria Weekes ceasing to be a director as of May 30, 2025. This update, in compliance with ASX Listing Rule 3.19A.3, is part of the company’s ongoing corporate governance and may impact its strategic direction as it continues to expand its healthcare technology services globally.

The most recent analyst rating on (AU:ALC) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.

More about Alcidion Group Limited

Alcidion Group Limited is a company focused on transforming healthcare through innovative technology solutions that enhance the efficiency and quality of patient care globally. The company offers a suite of software products and technical services, with its flagship product, Miya Precision, providing centralized dashboards, interoperability support, communication facilitation, task management, and clinical decision support. Alcidion has expanded its presence in the UK, Australia, and New Zealand, servicing over 400 hospitals and 87 healthcare organizations, with plans for further geographical expansion.

Average Trading Volume: 1,376,290

Technical Sentiment Signal: Buy

Current Market Cap: A$108.8M

Find detailed analytics on ALC stock on TipRanks’ Stock Analysis page.